Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2008;336:729-730 (5 April), doi:10.1136/bmj.39503.508484.80 (published 28 February 2008)
Recognising and targeting differences between population groups are the priorities
| The first 150 words of the full text of this article appear below. |
Almost a decade since the original report suggesting a link between the combined measles, mumps, and rubella (MMR) vaccine and autism or inflammatory bowel disease, we now have overwhelming evidence to refute such a link.1 Some people, however, still refuse to have their children vaccinated for MMR, and sometimes replace the combined vaccine with single antigen vaccines. In the accompanying study, Pearce and colleagues report uptake of the combined MMR vaccine and single antigen vaccines and they discuss the factors influencing uptake in a three year follow-up of the UK millennium cohort.2
Low MMR vaccine coverage is not a trivial matter, because the accumulation of unvaccinated children will increase the risk of measles outbreaks. Confirmed cases of measles in England and Wales rose from 56 in 1998 to 971 in 2007 (figure
).3 In the United Kingdom, coverage for MMR at 24 months is lower than for other vaccines (85%
Peter McIntyre, director, Julie Leask, research fellow
1 National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, The Childrens Hospital at Westmead, NSW 2145, Australia
PeterM@chw.edu.au
Read all Rapid Responses
What can you learn from this BMJ paper? Read Leanne Tite's Paper+